1994
DOI: 10.1093/protein/7.2.145
|View full text |Cite
|
Sign up to set email alerts
|

Production of linear polymers of HIV go120-binding domains

Abstract: It has been demonstrated previously that molecular decoys of the acetylcholine receptor have therapeutic efficacy as antitoxins [Gershoni, J. and Aronheim, A. (1988) Proc. Natl Acad. Sci. USA, 85, 4087-4089], but surely a most challenging goal is to apply this approach towards the development of antiviral drugs. As viruses present multiple copies of their envelope proteins, it was proposed that polyvalent decoys could be advantageous. Here we report the design and expression of recombinant linear polymers of t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

1996
1996
2012
2012

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
2
0
1
Order By: Relevance
“…Other studies of tandem gene arrays have focused on increasing binding avidity (33), introducing a high concentration of antisense sequences (34), determining whether identical domains fold independently (35), and producing polymers to increase protein stability (36). In addition, genetic drift between domains may produce homologous but not identical sequences, which in turn may facilitate the ability of the domains to fold independently (35).…”
Section: Discussionmentioning
confidence: 99%
“…Other studies of tandem gene arrays have focused on increasing binding avidity (33), introducing a high concentration of antisense sequences (34), determining whether identical domains fold independently (35), and producing polymers to increase protein stability (36). In addition, genetic drift between domains may produce homologous but not identical sequences, which in turn may facilitate the ability of the domains to fold independently (35).…”
Section: Discussionmentioning
confidence: 99%
“…For this, the GIL-encoding sequences (GIL inserts) were cloned into the asymmetric AvaI site (CTCGGG) found in the modified MBP expression vector pMalC-133-AvaI (see Materials and Methods). We previously demonstrated that cloning inserts into such AvaI sites drives the formation of tandem repeats of the inserts in the proper reading frame and orientation [15]. This is due to the fact that the internal asymmetry of the restriction site generates two different 5 0 overhangs, thereby forcing compatible inserts to clone in only one orientation.…”
Section: Production Of Gil-specific Polyclonal Serummentioning
confidence: 99%
“…[191] Tabelle 5 enthält weitere Beispiele zur Zell-Zell-Wechselwirkung. [84] P: Transportprotein für Aminosäuren [85] Nichtökotropisches Mäuse-Leukämievirus Leukämie P: gp70 (Oberfläche) [86] HIV-1 AIDS P: gp120-ähnlicher Bereich der schweren Kette (Ig) P: gp120-ähnliches Neuroleukin P: gp120-ähnliches Vasoactive Intestinal Peptide [87,88] P: CD4 der T-Zellen P: CD4-Molekül wechselwirkt mit Klasse-II-HLA-DR-MHC Z: Galactosylceramid (oder nahe verwandtes Molekül auf epithelialen HT29-Zellen im menschlichen Dickdarm) P: CR2, besonders in Zellen, die mit EBV infiziert sind P: Chemokin-Rezeptoren CXCR-4 (T-Zell-trophisch) und CCR-5 (Makrophagen-trophisch) ± beide sind G-Protein-gekoppelte Rezeptoren mit sieben Transmembranhelices [89] HIV-2 AIDS P: CD4 [90] Simian Immunodeficiency Virus (SIV) Immunschwächesyndrom analog zu AIDS bei Affen P: SIV mac239 [91] P: CD4 Afrikanisches Schweinevirus P: p12, p72 [92,93] [a] P Protein, Z Zucker (Glycoprotein oder Glycolipid). [98] Z: Fucose-enthaltende Glycoside [99] auf Epitheloberfläche…”
Section: Bindung Von Zellen An Andere Zellen: Neutrophile Und Arterieunclassified